JP2004520810A - 腫瘍の診断と治療のための組成物と方法 - Google Patents
腫瘍の診断と治療のための組成物と方法 Download PDFInfo
- Publication number
- JP2004520810A JP2004520810A JP2002522275A JP2002522275A JP2004520810A JP 2004520810 A JP2004520810 A JP 2004520810A JP 2002522275 A JP2002522275 A JP 2002522275A JP 2002522275 A JP2002522275 A JP 2002522275A JP 2004520810 A JP2004520810 A JP 2004520810A
- Authority
- JP
- Japan
- Prior art keywords
- seq
- antibody
- tat
- polypeptide
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/645—Polycationic or polyanionic oligopeptides, polypeptides or polyamino acids, e.g. polylysine, polyarginine, polyglutamic acid or peptide TAT
- A61K47/6455—Polycationic oligopeptides, polypeptides or polyamino acids, e.g. for complexing nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2000/023328 WO2001016318A2 (en) | 1999-09-01 | 2000-08-24 | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| PCT/US2000/032678 WO2001040466A2 (en) | 1999-12-01 | 2000-12-01 | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| PCT/US2001/006520 WO2001068848A2 (en) | 2000-03-01 | 2001-02-28 | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| PCT/US2001/017800 WO2001093983A1 (en) | 2000-06-02 | 2001-06-01 | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| PCT/US2001/019692 WO2002000690A2 (en) | 2000-06-23 | 2001-06-20 | Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
| PCT/US2001/021066 WO2002008288A2 (en) | 2000-07-20 | 2001-06-29 | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| PCT/US2001/021735 WO2002008284A2 (en) | 2000-07-20 | 2001-07-09 | Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
| PCT/US2001/026626 WO2002016602A2 (en) | 2000-08-24 | 2001-08-23 | Compositions and methods for the diagnosis and treatment of tumor |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2005363921A Division JP2006104212A (ja) | 2000-08-24 | 2005-12-16 | 腫瘍の診断と治療のための組成物と方法 |
| JP2006252159A Division JP2007077155A (ja) | 2000-08-24 | 2006-09-19 | 腫瘍の診断と治療のための組成物と方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004520810A true JP2004520810A (ja) | 2004-07-15 |
| JP2004520810A5 JP2004520810A5 (cg-RX-API-DMAC7.html) | 2005-03-17 |
Family
ID=27567433
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002522275A Pending JP2004520810A (ja) | 2000-08-24 | 2001-08-23 | 腫瘍の診断と治療のための組成物と方法 |
Country Status (5)
| Country | Link |
|---|---|
| JP (1) | JP2004520810A (cg-RX-API-DMAC7.html) |
| AU (2) | AU8678501A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2420193A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MXPA03001643A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2002016602A2 (cg-RX-API-DMAC7.html) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006166779A (ja) * | 2004-12-15 | 2006-06-29 | National Institute Of Advanced Industrial & Technology | 核酸分解酵素 |
| WO2006082851A1 (ja) * | 2005-02-02 | 2006-08-10 | The University Of Tokyo | エピグリカニン関連ムチン |
| JP2009537154A (ja) * | 2006-05-18 | 2009-10-29 | モレキュラー プロファイリング インスティテュート, インコーポレイテッド | 疾患状態に対する個別化された医学的介入を決定するためのシステムおよび方法 |
| JP2014138588A (ja) * | 2007-07-27 | 2014-07-31 | Immatics Biotechnologies Gmbh | 免疫療法用の新規免疫原性エピトープ |
| US11180535B1 (en) | 2016-12-07 | 2021-11-23 | David Gordon Bermudes | Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria |
| US12366585B2 (en) | 2006-05-18 | 2025-07-22 | Caris Mpi, Inc. | Molecular profiling of tumors |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030228319A1 (en) * | 2002-04-16 | 2003-12-11 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of tumor |
| US20050123925A1 (en) * | 2002-11-15 | 2005-06-09 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of tumor |
| EP2305710A3 (en) | 2002-06-03 | 2013-05-29 | Genentech, Inc. | Synthetic antibody phage libraries |
| ES2456696T3 (es) * | 2002-09-11 | 2014-04-23 | Genentech, Inc. | Composiciones y métodos para el diagnóstico y el tratamiento de tumores |
| AU2003303144A1 (en) * | 2002-10-18 | 2004-07-29 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of tumor |
| CN100473664C (zh) * | 2002-12-20 | 2009-04-01 | 拜奥根Idec马萨诸塞公司 | 多价淋巴毒素β受体激动剂及其治疗用途 |
| CA2530884C (en) | 2003-07-02 | 2016-01-12 | Genentech, Inc. | Trp-p8 active compounds and therapeutic treatment methods |
| RU2007104022A (ru) | 2004-07-02 | 2008-08-10 | Дженентек, Инк. (Us) | Композиции для лечения неходжкинской лимфомы и способы их применения |
| PL2242772T3 (pl) | 2007-12-26 | 2015-05-29 | Biotest Ag | Immunokonjugaty nakierowane na CD138 i ich zastosowanie |
| US9446146B2 (en) | 2007-12-26 | 2016-09-20 | Biotest Ag | Methods and agents for improving targeting of CD138 expressing tumor cells |
| ES2475201T3 (es) | 2007-12-26 | 2014-07-10 | Biotest Ag | Agentes dirigidos contra CD138 y usos de los mismos |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3909799A1 (de) * | 1989-03-24 | 1990-09-27 | Behringwerke Ag | Monoklonale antikoerper (mak) gegen tumorassoziierte antigene, ihre herstellung und verwendung |
| US6312922B1 (en) * | 1998-02-09 | 2001-11-06 | Genset | Complementary DNAs |
| ES2312205T3 (es) * | 1998-03-10 | 2009-02-16 | Genentech, Inc. | Nuevo polipeptido y acidos nucleicos que lo codifican. |
| NZ510464A (en) * | 1998-09-01 | 2004-05-28 | Genentech Inc | Further pro polypeptides and sequences thereof |
| JP2002527757A (ja) * | 1998-10-19 | 2002-08-27 | ダイアデクスアス・インコーポレーテッド | 前立腺癌を診断、監視、病期分類、イメージング及び治療する方法 |
-
2001
- 2001-08-23 JP JP2002522275A patent/JP2004520810A/ja active Pending
- 2001-08-23 CA CA002420193A patent/CA2420193A1/en not_active Abandoned
- 2001-08-23 MX MXPA03001643A patent/MXPA03001643A/es not_active Application Discontinuation
- 2001-08-23 AU AU8678501A patent/AU8678501A/xx active Pending
- 2001-08-23 AU AU2001286785A patent/AU2001286785B2/en not_active Ceased
- 2001-08-23 WO PCT/US2001/026626 patent/WO2002016602A2/en not_active Ceased
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006166779A (ja) * | 2004-12-15 | 2006-06-29 | National Institute Of Advanced Industrial & Technology | 核酸分解酵素 |
| WO2006082851A1 (ja) * | 2005-02-02 | 2006-08-10 | The University Of Tokyo | エピグリカニン関連ムチン |
| JP2009537154A (ja) * | 2006-05-18 | 2009-10-29 | モレキュラー プロファイリング インスティテュート, インコーポレイテッド | 疾患状態に対する個別化された医学的介入を決定するためのシステムおよび方法 |
| US12366585B2 (en) | 2006-05-18 | 2025-07-22 | Caris Mpi, Inc. | Molecular profiling of tumors |
| JP2014138588A (ja) * | 2007-07-27 | 2014-07-31 | Immatics Biotechnologies Gmbh | 免疫療法用の新規免疫原性エピトープ |
| US11180535B1 (en) | 2016-12-07 | 2021-11-23 | David Gordon Bermudes | Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria |
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA03001643A (es) | 2004-05-14 |
| AU8678501A (en) | 2002-03-04 |
| AU2001286785B2 (en) | 2006-08-17 |
| WO2002016602A2 (en) | 2002-02-28 |
| CA2420193A1 (en) | 2002-02-28 |
| WO2002016602A3 (en) | 2003-02-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4822710B2 (ja) | 腫瘍の診断と治療のための組成物と方法 | |
| JP4912356B2 (ja) | 腫瘍の診断及び治療のための組成物及び方法 | |
| US7514538B2 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
| JP5587841B2 (ja) | 造血系起源の腫瘍の治療のための組成物と方法 | |
| JP4703567B2 (ja) | 膠細胞起源の腫瘍の診断と治療のための組成物と方法 | |
| JP2004520806A (ja) | 腫瘍の診断と治療のための組成物と方法 | |
| US20060062727A1 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
| JP2006516089A (ja) | 腫瘍の診断と治療のための組成物と方法 | |
| JP2005536190A (ja) | 腫瘍の診断と治療のための組成物と方法 | |
| JP2006516192A (ja) | 腫瘍の診断と治療のための組成物と方法 | |
| JP2006510735A (ja) | 腫瘍の診断と治療のための組成物と方法 | |
| JP2008137989A (ja) | 腫瘍の診断と治療のための組成物と方法 | |
| JP2012046515A (ja) | 腫瘍の診断と治療のための組成物と方法 | |
| JP2005528905A (ja) | 腫瘍の診断と治療のための組成物と方法 | |
| JP2007519632A5 (cg-RX-API-DMAC7.html) | ||
| AU2001286785B2 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
| US8097700B2 (en) | TAT294 polypeptides | |
| JP2007521791A (ja) | 腫瘍の診断と治療のための組成物と方法 | |
| JP2007077155A (ja) | 腫瘍の診断と治療のための組成物と方法 | |
| JP2004520808A (ja) | 腫瘍の診断と治療のための組成物と方法 | |
| JP2007512019A (ja) | 腫瘍の診断と治療のための組成物と方法 | |
| JP2006516655A (ja) | 腫瘍の診断と治療のための組成物と方法 | |
| US20050159588A1 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
| KR100607610B1 (ko) | 종양의 진단 및 치료를 위한 방법 및 이를 위한 조성물 | |
| US20070031901A1 (en) | Compositions and methods for the diagnosis and treatment of tumor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20050920 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20051216 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20060328 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20060628 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20060705 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20070424 |